¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"adrenergic neuron"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® neuron ÇÑ±Û ´º·±, ½Å°æ¿ø
¼³¸í   
  ÇϳªÀÇ ½Å°æ¼¼Æ÷¸¦ À̸¥´Ù. ½Å°æ¼¼Æ÷ÀÇ ±¸Á¶´Â ¿Ã¹Ù¸¥ ½Å°æÀü´ÞÀ» À§ÇÑ °¢ ºÎºÐº°·Î ³ª´µ¾îÁ® ÀÖ´Ù. Áï À§¿¡¼­ ÀüÇØÁ® ³»·Á¿À´Â ½Å°æÀÚ±ØÀº °¡Áöµ¹±â¸¦ ÅëÇØ ¹Þ¾ÆÁ®¼­, ±× ½Å°æ¼¼Æ÷ ¸·À» µû¶ó Àü±âÀû ÀÚ±ØÀ¸·Î ¹Ù²î¾îÁ® ³»·Á°¡°Ô µÈ´Ù. ¼ö»óµ¹±â¿¡¼­ ¼¼Æ÷ü, ±×¸®°í Ãà»èÀ¸·Î °Ç³»¾îÁ® ½Å°æÁ¾¸»¿¡ À̸£·¯ ±ÙÀ°À̳ª, È¤Àº ´Ù¸¥ ½Å°æÁ¶Á÷À¸·Î Àü´ÞµÇ¾î Áö´Â °ÍÀÌ´Ù. À̶§ Ãà»èÁÖÀ§¿¡´Â Àý¿¬Ã¼ÀΠ¸»ÀÌÁý(myelin sheath)°¡ µÑ·¯½Î¿©Á® ÀÖ°í °¢ ¼öÃÊ»çÀÌ¿¡´Â ÀýÈçÀÌ Á¸ÀçÇϴµ¥ À̰ÍÀ» ¶õºñ¿¡ °áÀý(Ranvier's node)À̶ó ºÎ¸¥´Ù. ½Å°æÀü´ÞÀÌ »¡¸® ÀÌ·ç¾îÁöµµ·Ï ÇϱâÀ§ÇØ °íµî»ý¹°¿¡ Á¸ÀçÇϴ ¶õºñ¿¡ °áÀýÀº ÀÌ °áÀýµé»çÀ̷θ¸ ½Å°æÀü´ÞÀÌ ÀÌ·ç¾îÁ® º¸´Ù ºü¸¥ Àü´ÞÀÌ ÀϾ´Ù.
  
  ½Å°æ¼¼Æ÷ÀÇ ºÐ·ù´Â ÁַΠ±â´ÉÀ̳ª, È¤Àº ±× Àü´ÞÀÇ ¹æÇâ¿¡ µû¶ó ºÐ·ùÇÏÁö¸¸, ¸»ÃʽŰæÁß Áß¿äÇÑ ½Å°æÀ̳ª, ÁßÃ߽ŰæÀº °¢±â ±× ¸íĪÀÌ Á¤ÇØÁ® ÀÖ´Ù. Áï, ¡°¿îµ¿½Å°æ(¿îµ¿À» ´ã´çÇϴ ½Å°æÁ¶Á÷. ÁַΠ»çÁö¸»´Ü¿¡ ºÐÆ÷ÇÑ´Ù)¡±, ¡°°¨°¢½Å°æ(°¨°¢À» ´ã´çÇϴ ½Å°æÁ¶Á÷À¸·Î Åë°¢, ¿Âµµ°¨°¢, Ã˰¢ µîÀ» ³ú·Î Àü´ÞÇØÁִ ¿ªÇÒÀ» ÇÑ´Ù)¡± µîÀ¸·Î ºÒ¸®¿öÁö°Å³ª, ¶Ç´Â ¡°µé½Å°æ(¹Û¿¡¼­ ¾ÈÀ¸·Î À¯ÀԵȴٴ ¶æÀ¸·Î ÁַΠ°¨°¢½Å°æÀ» ¶æÇÑ´Ù)¡± ¡°³¯½Å°æ(¾È¿¡¼­ ¹Ù±ùÀ¸·Î ÀÛ¿ëÀ» °¡ÇϱâÀ§ÇØ ³ª°£´Ù´Â ¶æÀ¸·Î ÁַΠ¿îµ¿½Å°æÀ̳ª ÀÚÀ²½Å°æÀ» ¶æÇÑ´Ù)¡±µîÀ¸·Î ºÒ¸®¿ö Áö°í, Áß¿äÇÑ ½Å°æÀΠ°æ¿ì´Â Á¤°­½Å°æ, Á¾¾Æ¸®½Å°æ µîÀ¸·Î °íÀ¯¸íĪÀÌ ºÙ¿©Á® ÀÖ´Ù
  
  ½Å°æ¼¼Æ÷¸¦ ÀÌ·ç°í Àִ ¸ðµç ºÎºÐ¿¡¼­ ÀÌ»óÀÌ ³ªÅ¸³¯ ¼ö ÀÖÀ¸¸ç, À̶§ ½Å°æÃ¼³ª È¤Àº ½Å°æÇÙÀÇ ¼Õ»óÀº ÁßÃ߽Űæ°è(ÁַΠ³ú¿¡¼­ Á÷Á¢ ºÐÁöµÇ¾î ³»·Á¿Â ½Å°æÀ» ¸»ÇÔ)¿¡¼­´Â Àç»ýµÉ ¼ö ¾øÀ¸¸ç, ÁÖÀ§ ¼öÃÊ µî¿¡ ÀÇÇÑ º´ÅÍ¿¡¼­´Â Àç»ýÀÌ °¡´ÉÇÏ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenergic
    1. ¾Æµå·¹³¯¸°- 2. ¾Æµå·¹³¯¸°¼º¾à
  • adrenergic antagonist
    ¾Æµå·¹³¯¸°´ëÇ×Á¦, ¾Æµå·¹³¯¸°±æÇ×Á¦
  • adrenergic blocker
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦
  • adrenergic drug
    ¾Æµå·¹³¯¸°ÀÛ¿ë¾à
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼¶À¯
  • adrenergic receptor
    ¾Æµå·¹³¯¸°¼ö¿ëü
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼ö¿ëüÀλêÈ­È¿¼Ò
  • association neuron
    ¿¬ÇսŰ漼Æ÷
  • autonomic neuron
    ÀÚÀ²½Å°æ¼¼Æ÷
  • alpha motor neuron
    ¾ËÆÄ¿îµ¿½Å°æ¼¼Æ÷
  • bipolar neuron
    µÎ±Ø½Å°æ¼¼Æ÷
  • commissural neuron
    ¸Â±³Â÷½Å°æ¼¼Æ÷
  • cholinergic neuron
    Äݸ°½Å°æ¼¼Æ÷
  • dopaminergic neuron
    µµÆÄ¹Î½Å°æ¼¼Æ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • upper motor neuron disease
    »óÀ§¿îµ¿½Å°æ¿øº´
  • neuron
    ½Å°æ¼¼Æ÷, ½Å°æ´ÜÀ§
  • bipolar neuron
    µÎ±Ø½Å°æ¼¼Æ÷
  • postganglionic neuron
    ½Å°æÀýÀÌÈĽŰ漼Æ÷
  • preganglionic neuron
    ½Å°æÀýÀÌÀü½Å°æ¼¼Æ÷
  • secretory neuron
    ºÐºñ½Å°æ¼¼Æ÷
  • upper motor neuron
    »óÀ§¿îµ¿½Å°æ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenergic
    ¾Æµå·¹³¯¸°¼º¾à, ¾Æµå·¹³¯¸°-
  • adrenergic blocker
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦
  • adrenergic drug
    ¾Æµå·¹³¯¸°ÀÛ¿ë¾à
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼¶À¯
  • adrenergic receptor
    ¾Æµå·¹³¯¸°¼ö¿ëü
  • adrenergic antagonist
    ¾Æµå·¹³¯¸°´ëÇ×Á¦
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • alpha motor neuron
    ¾ËÆÄ¿îµ¿½Å°æ¼¼Æ÷
  • association neuron
    ¿¬ÇսŰ漼Æ÷
  • autonomic neuron
    ÀÚÀ²½Å°æ¼¼Æ÷
  • bipolar neuron
    µÎ±Ø½Å°æ¼¼Æ÷
  • cholinergic neuron
    Äݸ°¼º½Å°æ¼¼Æ÷
  • commissural neuron
    ¸Â±³Â÷½Å°æ¼¼Æ÷
  • dopaminergic neuron
    µµÆÄ¹Î½Å°æ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenergic stimulating drug
    ¾Æµå·¹³¯¸°ÈïºÐ¾à, ¾Æµå·¹³¯¸°ÀÚ±ØÁ¦.
  • adrenergic tone
    ¾Æµå·¹³¯¸°¼º ±äÀåµµ
  • adrenergic transmission
    ¾Æµå·¹³¯¸°¼ºÀü´Þ
  • adrenergic urticaria
    ¾Æµå·¹³¯¸°¼º µÎµå·¯±â
  • adrenoceptor =adrenergic
    ¾Æµå·¹³¯¸°(¼º)¼ö¿ëü(áôé»ô÷).
  • alpha-adrenergic agonist
    ¾ËÆÄ¾Æµå·¹³¯¸°ÃËÁøÁ¦
  • alpha-adrenergic antagonist
    ¾ËÆÄ¾Æµå·¹³¯¸°±æÇ×Á¦
  • alpha-adrenergic receptor
    ¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
  • alpha-adrenergic receptor
    ¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
  • golgi type i neuron
    ±äÃà»è½Å°æ¼¼Æ÷
  • golgi type ii neuron
    ªÀºÃà»è½Å°æ¼¼Æ÷
  • horizontal neuron
    ¼öÆò¼¼Æ÷
  • pigment neuron
    »ö¼Ò½Å°æ¼¼Æ÷
  • piriform neuron layer [purkinjes layer]
    Á¶·Õ¹ÚÃþ
  • postganglionic neuron
    (½Å°æ)[ÇØºÎ]ÀýÈÄ´º¿ì·Ð.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenergic neuron
    ¾Æµå·¹³¯¸°¼º ½Å°æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • connector neuron =intercalated neuron, internnuncial neuron
    °³Àç(Ë¿ î¤)´º¿ì·Ð.
  • adrenergic
    ¾Æµå·¹³¯¸°¼º, ¾Æµå·¹³¯¸°ÀÛµ¿¼º, ¾Æµå·¹³¯¸°(¼º)¾à.
  • adrenergic agonist
    ¾Æµå·¹³¯¸°¼ºÃËÁøÁ¦
  • adrenergic antagonist
    ¾Æµå·¹³¯¸° ±æÇ×¹°Áú
  • adrenergic antagonist
    ¾Æµå·¹³¯¸°¼º ±æÇ×Á¦
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°Â÷´ÜÁ¦.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸°(¼º) ºÀ¼â<Â÷´Ü>¾à.
  • adrenergic drug =a. stimulating agent
    ¾Æµå·¹³¯¸°¾à.
  • adrenergic drug =a. stimulating agent
    ¾Æµå·¹³¯¸°¼º¾à¹°
  • adrenergic drug =a. stimulating agent
    ¾Æµå·¹³¯¸°(¼º)¾à.
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼º ¼¶À¯
  • adrenergic neurotransmitter
    ¾Æµå·¹³¯¸°¼º ½Å°æÀü´Þ¹°Áú
  • adrenergic receptor
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â,°¨¼öü)
  • adrenergic stimulating drug
    ¾Æµå·¹³¯¸°ÈïºÐ¾à, ¾Æµå·¹³¯¸°ÀÚ±ØÁ¦.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Multipolar neuron
    (ÀÚÀ²)¹µ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ù±Ø½Å°æ¿ø
  • Pseudounipolar neuron
    °ÅÁþȬ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] À§´Ü±Ø½Å°æ¿ø
  • Pseudo-unipolar neuron
    °ÅÁþȬ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] °¡´Ü±Ø½Å°æ¼¼Æ÷
  • Bipolar neuron
    µÎ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ¾ç±Ø½Å°æ¿ø
  • Commissural neuron
    ¸Â±³Â÷½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ±³·Ã½Å°æ¼¼Æ÷
  • Somatic neuron
    ¸ö½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ü¼º½Å°æ¼¼Æ÷
  • Multipolar neuron
    ¹µ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ù±Ø¼¼Æ÷
  • Multipolar neuron
    ¹µ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ù±Ø½Å°æ¼¼Æ÷
  • Multipolar neuron
    ¹µ±Ø½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ù±Ø½Å°æ¿ø
  • Noncommissural neuron
    ºñ¸Â±³Â÷½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ºñ±³·Ã½Å°æ¼¼Æ÷
  • Horizontal neuron
    ¼öÆò¼¼Æ÷
    [¿¾ ¿ë¾î] ¼öÆò½Å°æ¼¼Æ÷
  • Neuron of neuromuscular spindle
    ½Å°æ±ÙÀ°¹æÃ߽Ű漼Æ÷
    [¿¾ ¿ë¾î] ½Å°æ±Ù¹æÃ߽Ű漼Æ÷
  • Autonomic neuron
    ÀÚÀ²½Å°æ¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÚÀ²½Å°æ¼¼Æ÷
  • Small fusiform neuron
    ÀÛÀº¹æÃß¼¼Æ÷
    [¿¾ ¿ë¾î] ¼Ò¹æÃ߻󼼯÷
  • Small stellate neuron
    ÀÛÀºº°¼¼Æ÷
    [¿¾ ¿ë¾î] ¼Ò¼º»ó¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GABAergic neuron
    GABAÀÛµ¿¼º(íÂÔÑàõ) ½Å°æ¿ø(ãêÌèê«)
  • adrenergic
    ¾Æµå·¹³¯¸° ÀÛµ¿¼º(íÂÔÑàõ)
  • adrenergic receptor
    ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) ¼ö¿ëü(áôé»ô÷)
  • alpha adrenergic receptor
    ¾ËÆÄ¾Æµå·¹³ª¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷)
  • beta adrenergic blocker
    º£Å¸ ¾Æµå·¹³¯¸°ÀÛµ¿(íÂÔÑ) Â÷´ÜÁ¦(ó´Ó¨ð¥)
  • beta adrenergic receptor
    º£Å¸ ¾Æµå·¹³¯¸° ¼ö¿ëü(áôé»ô÷)
  • dopamine adrenergic receptor
    "µµÆÄ¹Î ¾Æµå·¹³¯¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷), (ÔÒ) adrenergic receptor"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neuron
    ´º¿ì·Ð, ½Å°æ¿ø
  • unipolar neuron
    ´Ü±Ø¼º ´º¿ì·Ð
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ADRA1C alpha-1C-adrenergic receptor
ADRBK beta-1-adrenergic receptor kinase
ADRBR adrenergic beta-receptor
ARB adrenergic receptor binder
ARM adrenergic receptor material; aerosol rebreathing method; ambulatory renal monitor; anorectal manome...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AR 1-Adrenergic receptor
alpha(2)-AR alpha(2B)-adrenergic receptor
AR Alpha1-adrenergic receptors
alpha1-ARs Alpha1-adrenergic receptors
beta 2AR Beta 2-adrenergic receptors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • 2-adrenergic agonist
    2-¾Æµå·¹³¯¸° ÀÛ¿ëÁ¦, 2-¾Æµå·¹³¯¸° ÀÛµ¿Á¦
  • adrenergic agonist
    ¾Æµå·¹³¯¸°¼º ÀÛµ¿¾à
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü¸¦ ÈïºÐ½ÃÅ´À¸·Î½á È¿°ú¸¦ ³ªÅ¸³»´Â ¾à¹°. ´ë°Ô ¾Æ¹Î È­ÇÕ¹°À̹ǷΠ±³°¨½Å°æ À¯»ç ¾Æ¹ÎÀ̶ó°íµµ ÇÑ´Ù.
  • adrenergic blocking agent
    ¾Æµå·¹³¯¸° Â÷´ÜÁ¦
    ¾Æµå·¹³¯¸°¼º ¼ö¿ëü¿¡ ÀÛ¿ëÇÏ¿© ½Å°æ Àü´Þü¿Í ¼ö¿ëü°¡ °áÇÕÇÏÁö ¸øÇÏ°Ô ÇÔÀ¸·Î½á ±³°¨½Å°æ ÈïºÐ È¿°ú¸¦ ºÀ¼âÇÏ´Â ¾à¹°.
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼º ¼¶À¯
  • adrenergic neurotransmitter
    ¾Æµå·¹³¯¸°¼º ½Å°æ Àü´Þ ¹°Áú
  • adrenergic stimulating drug
    ¾Æµå·¹³¯¸° ÈïºÐ ¾à, ¾Æµå·¹³¯¸°¼º ÈïºÐ¾à, ¾Æµå·¹³¯¸° ÀÚ±ØÁ¦, ¾Æµå·¹³¯¸°¼º ÀÚ±ØÁ¦
  • adrenergic transmission
    ¾Æµå·¹³¯¸°¼º Àü´Þ
    ³ë¸£¾Æµå·¹³¯¸° ¶Ç´Â ¾Æµå·¹³¯¸°À» Àü´Þ ¹°Áú·Î ÇÏ´Â ÈïºÐ Àü´Þ. ±³°¨½Å°æÀÇ ¹ß´ÜÀ» °ÅÀÇ À̰ÍÀÌ´Ù. ±³°¨ ½Å°æ ¼¶À¯°¡ ÈïºÐÇÏ¸é ¸»´Ü¿¡¼­ ³ë¸£¾Æµå·¹³¯¸° µîÀÌ ¹æÃâµÇ°í À̰ÍÀÌ È¿°ú±âÀÇ ¼ö¿ë±â¿¡ µµ´ÞÇØ ÈïºÐµÈ´Ù. ÈïºÐ
  • adrenergic urticaria
    ¾Æµå·¹³¯¸°¼º µÎµå·¯±â
  • alpha 1-adrenergic blocker
    ¾ËÆÄ 1-¾Æµå·¹³¯¸°¼º Â÷´Ü
  • alpha adrenergic antagonist
    ¾ËÆÄ ¾Æµå·¹³¯¸° ±æÇ×Á¦
  • alpha-adrenergic receptor
    ¾ËÆÄ-¾Æµå·¹³¯¸° ¼ö¿ëü
  • beta-adrenergic blocking agent
    º£Å¸ ¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
  • ¥â-adrenergic

    ¥â-adrenergic agent (

    ¥â-adrenergic receptor blocking agent (º£Å¸ ¾Æµå·¹³¯¸°¼º ¼ö¿ëü Â÷´ÜÁ¦

  • alpha efferent motor neuron
    ¾ËÆÄ ¿ø½É ¿îµ¿ ´º¿ì·±, ¾ËÆÄ ¿ø½É¼º ¿îµ¿ ´º·±
  • amputation neuron
    Àý´Ü ½Å°æÁõ
    ¿Ü»ó¼º ½Å°æÁõÀ̶ó°íµµ ÇÏ¸ç ¿Ü»ó ÈÄ¿¡ ¾ß±âµÇ´Â ½Å°æ¼¶À¯ÀÇ µ¢¾î¸® ¸ð¾çÀÇ °úÀ× Àç»ýÀ¸·Î ÁøÁ¤ÇÑ ÀǹÌÀÇ Á¾¾çÀº ¾Æ´Ï´Ù. »óÇÏ¾Ç ¾îµð¼­³ª ¹ß»ýµÇÁö¸¸ ÇÏ¾Ç À̰øºÎ¿¡¼­ È£¹ßÇÑ´Ù. ¹ßÄ¡ ÈÄ¿¡ ¶Ç´Â °ñÀýÀ̳ª ¼ö¼ú ÈÄ¿¡ Àß ¹ß»ýµÇ¸ç ÀÇÄ¡ »ó¿¬ÀÇ ¾Ð¹ÚÀ¸·Î ÇÏ¾Ç À̰øºÎ¿¡¼­ ¹ß»ýµÇ±âµµ ÇÑ´Ù. ÇϼøÀ̳ª Çô¿¡¼­ ¹ß»ýµÇ´Â °æ¿ìµµ ÀÖ´Ù. Å©±â´Â Á÷°æÀÌ 1cm ³»¿ÜÀÌ¸ç ¾ÐÅëÀ̳ª Áö°¢ ÀÌ»óÀ» º¸À̰í Á¶Á÷ÇÐÀûÀ¸·Î ½Å°æ ¼¶À¯°¡ °áÀý¼ºÀ¸·Î Áõ½ÄÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
adrenergic neuronal blocking agent A drug that prevents the release of norepinephrine from sympathetic nerve terminals; it does not inhibit the responses of the adrenergic receptors to circulating epinephrine, norepinephrine, and other adrenergic amines.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adrenergic <neurology, physiology> Refers to neurons that use catecholamines as neurotransmitters at a synapse when a nerve impulse passes i.e. The sympathetic fibres.
Also refers to neurones that are activated by, characteristic of or secreting adrenaline (adrenaline) or substances with similar activity.
(15 Jan 1998)
adrenergic agents Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.
(12 Dec 1998)
adrenergic agonists Drugs that bind to and activate adrenergic receptors.
(12 Dec 1998)
adrenergic alpha-agonists Drugs that selectively bind to and activate alpha adrenergic receptors.
(12 Dec 1998)
adrenergic alpha-antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
(12 Dec 1998)
adrenergic amine An agent that evokes responses similar to those produced by adrenergic nerve activity (e.g., epinephrine, ephedrine, isoproterenol).
Synonym: adrenergic amine, adrenomimetic amine, sympathetic amine.
(05 Mar 2000)
adrenergic antagonists Drugs that bind to but do not activate adrenergic receptors. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters epinephrine and norepinephrine.
(12 Dec 1998)
adrenergic beta-agonists Drugs that selectively bind to and activate beta-adrenergic receptors.
(12 Dec 1998)
adrenergic beta-antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
(12 Dec 1998)
adrenergic blockade Selective inhibition by a drug of the responses of effector cells to adrenergic sympathetic nerve impulses (sympatholytic) and to epinephrine and related amines (adrenolytic).
(05 Mar 2000)
adrenergic blocking agent A compound that selectively blocks or inhibits responses to sympathetic adrenergic nerve activity (sympatholytic agent) and to epinephrine, norepinephrine, and other adrenergic amines (adrenolytic agent); two distinct classes exist, alpha-and beta-adrenergic receptor blocking agent's.
(05 Mar 2000)
adrenergic bronchodilator <pharmacology> A medication that acts to dilate (enlarge) the lumen of the airway to allow the unrestricted passage of air. These medications are commonly given to those with asthma who manifest wheezing.
Examples include: theophylline, aminophylline, adrenaline, Alupent, metaproterenol, isoproterenol, Ventolin, Proventil, bitolterol, salmeterol, pirbuterol and albuterol.
See: wheezing.
(27 Sep 1997)
adrenergic fibres Nerve fibres liberating catecholamines at a synapse after an impulse.
(12 Dec 1998)
adrenergic receptors Reactive components of effector tissues, most of which are innervated by adrenergic postganglionic fibres of the sympathetic nervous system. Such receptor's can be activated by norepinephrine and/or epinephrine and by various adrenergic drugs; receptor activation results in a change in effector tissue function, such as contraction of arteriolar muscles or relaxation of bronchial muscles; adrenergic receptor's are divided into alpha-receptor's and beta-receptor's, on the basis of their response to various adrenergic activating and blocking agents.
Synonym: adrenoceptor, adrenoreceptors.
(05 Mar 2000)
adrenergic uptake inhibitors Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (antidepressive agents, tricyclic) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
adrenergic neuron b. see adrenergic b.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
adrenergic neuron blocking a. one that inhibits the release of norepinephrine from postganglionic adrenergic nerve endings.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
adrenergic neuron-blocking agents Substances that inhibit transmission of sympathetic nerve stimuli regardless of whether alpha- or beta-adrenergic receptors are involved. SEE: receptor, alpha-adrenergic; beta-adrenergic receptor.
Ãâó:
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neuron
    ½Å°æ´ÜÀ§(¼¼Æ÷)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á